Medscape Hematology-Oncology Headlines This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

How Can Dermatologists Improve Cancer Care? How Can Dermatologists Improve Cancer Care?
Dermatologists play a key role on interdisciplinary treatment teams.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - December 7, 2023 Category: Cancer & Oncology Tags: Dermatology Source Type: news

FDA OKs Iptacopan to Treat Paroxysmal Nocturnal Hemoglobinuria FDA OKs Iptacopan to Treat Paroxysmal Nocturnal Hemoglobinuria
This marks the first oral monotherapy approved for the rare blood disorder.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - December 6, 2023 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news

What Will Help Ease the Financial Toll of Breast Cancer? What Will Help Ease the Financial Toll of Breast Cancer?
Programs that offer financial assistance and transportation as well as grants that help cover expenses are among the key strategies that can help reduce the financial stress of breast cancer care.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - December 6, 2023 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news

Even With Insurance, Cancer OOP Costs Can Be Punishing Even With Insurance, Cancer OOP Costs Can Be Punishing
Commercial health insurance does not necessarily protect cancer patients from potentially devastating out-of-pocket costs.MDedge News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - December 5, 2023 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news

ASH 2023: Equity, Sickle Cell, and Real-Life Outcomes ASH 2023: Equity, Sickle Cell, and Real-Life Outcomes
Health equity, sickle cell disease, and the thoughtful use of artificial intelligence and social media are among the key themes to be presented at the annual meeting of the American Society of Hematology.MDedge News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - December 5, 2023 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

How the Microbiome Influences the Success of Cancer Therapy How the Microbiome Influences the Success of Cancer Therapy
Microbial diversity affects whether a tumor grows, leads to inflammation, develops immune escape mechanisms, or develops therapeutic resistance, said an internal medicine specialist.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - December 4, 2023 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

FDA Approves Pirtobrutinib for Previously Treated CLL/SLL FDA Approves Pirtobrutinib for Previously Treated CLL/SLL
The approval is the second this year for the reversible, highly selective kinase inhibitor following a January approval in mantle cell lymphoma.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - December 4, 2023 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news

SABCS 2023 Highlights Breast Cancer De-Escalation SABCS 2023 Highlights Breast Cancer De-Escalation
From humble beginnings in 1977, 10,000 people are expected to attend this year ' s breast cancer meeting in San Antonio.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - December 1, 2023 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Sabcs 2023 sabcs 2023
Read clinically focused news coverage of key developments from SABCS 2023Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - December 1, 2023 Category: Cancer & Oncology Tags: Hematology-Oncology Conference Coverage Source Type: news

Time to Stop Routine Maintenance Therapy in Myeloma? Time to Stop Routine Maintenance Therapy in Myeloma?
Physicians may need to rethink maintenance with lenalidomide (Revlimid and generics) for multiple myeloma.MDedge News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - December 1, 2023 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news

Pancreatic Cystic Neoplasms Rarely Turn Cancerous Pancreatic Cystic Neoplasms Rarely Turn Cancerous
Individuals with intraductal papillary mucinous neoplasms that lack ' worrisome or high-risk features ' have no greater risk of pancreatic cancer than individuals without IPMNs.MDedge News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - November 30, 2023 Category: Cancer & Oncology Tags: Gastroenterology News Source Type: news

New Column: Practical AI With Arturo Loaiza-Bonilla New Column: Practical AI With Arturo Loaiza-Bonilla
An expert on artificial intelligence and precision medicine in cancer care introduces his new column.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - November 30, 2023 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news

Avoid Anti-HER2 Cancer Therapies During Pregnancy Avoid Anti-HER2 Cancer Therapies During Pregnancy
Women with HER2-positive breast cancer who receive HER2-targeted therapies during pregnancy face a higher risk for severe adverse outcomes to their fetus or newborn, new research indicates.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - November 29, 2023 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

FDA Investigates Secondary Cancers From CAR T-Cell Therapies FDA Investigates Secondary Cancers From CAR T-Cell Therapies
The FDA has determined that the risk for lymphoma and other T-cell cancers may apply to approved BCMA- and CD-19 –directed CAR T-cell immunotherapies.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - November 28, 2023 Category: Cancer & Oncology Tags: Hematology-Oncology News Alert Source Type: news

FDA OKs New Agent to Block Chemotherapy-Induced Neutropenia FDA OKs New Agent to Block Chemotherapy-Induced Neutropenia
The new colony-stimulating factor from China proved comparable to pegfilgrastim (Neulasta) in clinical testing.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - November 28, 2023 Category: Cancer & Oncology Tags: Hematology-Oncology News Alert Source Type: news